Regeneron Pharma (REGN) Posts Q1 Loss of $0.49, Wider than Views

May 3, 2011 7:04 AM EDT
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q1 loss of ($0.49), $0.13 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $112.2 million versus the consensus estimate of $117.02 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings